FDA Inspection
Accra-Pac, Inc.Accra-Pac, Inc. – FDA Inspection, Sep 2, 2022
Record Details
This FDA Inspection record concerns Accra-Pac, Inc., with an inspection on September 2, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Accra-Pac, Inc.
- Inspection Date
- September 2, 2022
- Product Type
- Drugs
View Company Profile
ID · 88b44c01-a15d-4051-87e3-3848c5e76845
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1178990
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
Other FDA inspections of Accra-Pac, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2026 | Not classified | Detroit District Office | Drug Quality Assurance |
| November 5, 2021 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| April 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Accra-Pac, Inc.
- FDA Inspection 1288190 - 2026-03-05
- FDA Inspection 1157187 - 2021-11-05
- FDA Inspection 1009786 - 2017-04-05
- FDA Inspection 904407 - 2014-11-21
- FDA Inspection 855917 - 2013-11-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.